BIOVAC V

1,470.00

Category: Tag:

Description

BIOVAC V is a preparation of the live, attenuated varicella virus. It is indicated for active immunization for the prevention of Varicella (Chickenpox) in individuals 12 months of age and older.

Immunization Guideline:

Each dose is approximately 0.5 mL after reconstitution and is administered by subcutaneous injection.

  • In children (12 months to 12 years of age), 2 doses at a minimum interval of 3 months should be given
  • In adolescents (≥13 years of age), 2 dose at a minimum interval of 4 weeks should be given
  • In adults 2 doses, to be administered at minimum interval of 4 weeks should be given

Additional information

manufacturer

Wockhardt

package-size

1 Dose

pharmaceutical-form

Lyophilized

route-of-administration

Subcutaneous

vaccine-type

chickenpox

Contraindications

History of severe allergic reaction to any component of the vaccine (including neomycin and gelatin) or to a previous dose of varicella vaccine. Primary or acquired immunodeficiency states. Any febrile illness or active infection, including untreated tuberculosis. Pregnancy.

country-of-manufacture

China